David C. Busse

1.0k citations
7 papers · 760 · 1 hit paper · h-index 6

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • Viral gastroenteritis research and epidemiology
  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • interferon and immune responses

Papers in

    • Influenza Virus Research Studies 5
    • Respiratory viral infections research 2
    • Virology and Viral Diseases 1
    • interferon and immune responses 3
    • Immune Response and Inflammation 2

David C. Busse

7 papers receiving 736 citations

David C. Busse's Hit Papers

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses 2017 · 379 citations
3790+3+6Years since publication100200300

Peers

David C. Busse
Comparison fields: 5 of 89
  • Infectious Diseases 241
  • Immunology 196
  • Animal Science and Zoology 60
  • Molecular Medicine 28
  • Molecular Biology 339
Replace Shih‐Tung Liu with:
Shih‐Tung Liu Taiwan
Emily P. Thi Canada
Dandan Dong China
Sirenia González‐Pozos Mexico
Jadranka Bozja United States
Anna Bogdanova Russia
Vibhu Kanchan India
Xia Cai China
Leilei Yang China
Sherry L. Kurtz United States
David C. Busse relative to Shih‐Tung Liu Taiwan Shih‐Tung Liu's profile →
Citations per field
00.5×2.7×
Shih‐Tung Liu · 1×
Citations per year

Countries citing papers authored by David C. Busse

Since Specialization
Citations

This map shows the geographic impact of David C. Busse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Busse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Busse more than expected).

Fields of papers citing papers by David C. Busse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Busse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Busse. The network helps show where David C. Busse may publish in the future.

Co-authors

The 25 scholars most cited alongside David C. Busse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David C. Busse Line = papers co-authored together David C. Busse links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
Hit paper breakdown →
2017379
2 2015193
3 202072
4 201856
5 201936
6 201921
7 20193

About David C. Busse

David C. Busse is a scholar working on Epidemiology, Immunology, Infectious Diseases, Ecology and Endocrinology, having authored 7 papers that have together received 760 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (5 papers), interferon and immune responses (3 papers), Immune Response and Inflammation (2 papers), Respiratory viral infections research (2 papers), Plant Virus Research Studies (1 paper), Virology and Viral Diseases (1 paper), Vibrio bacteria research studies (1 paper) and Bacteriophages and microbial interactions (1 paper). The work is most often cited by research in Infectious Diseases (241 citations), Immunology (196 citations), Animal Science and Zoology (60 citations), Molecular Medicine (28 citations) and Molecular Biology (339 citations). David C. Busse has collaborated with scholars based in United Kingdom, France and Germany. Frequent co-authors include John S. Tregoning, Nicole Jackson, Christopher P. Randall, Arya Gupta, Alex J. O’Neill, Lena Wicke, Kerstin C. Reuter, Uğur Şahin, Mario Perković and Ekaterina Kinnear. Their work appears in journals such as Journal of Virology, Frontiers in Immunology, Molecular Therapy, Journal of Antimicrobial Chemotherapy and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact